[HTML][HTML] The IL-8/IL-8R axis: a double agent in tumor immune resistance

JM David, C Dominguez, DH Hamilton, C Palena - Vaccines, 2016 - mdpi.com
Interleukin-8 (IL-8, CXCL8) is a pro-inflammatory chemokine produced by various cell types
to recruit leukocytes to sites of infection or tissue injury. Acquisition of IL-8 and/or its …

[HTML][HTML] Roles of the CXCL8-CXCR1/2 axis in the tumor microenvironment and immunotherapy

ZJ Han, YB Li, LX Yang, HJ Cheng, X Liu, H Chen - Molecules, 2021 - mdpi.com
In humans, Interleukin-8 (IL-8 or CXCL8) is a granulocytic chemokine with multiple roles
within the tumor microenvironment (TME), such as recruiting immunosuppressive cells to the …

CXCL8 Signaling in the Tumor Microenvironment

S Asokan, OR Bandapalli - … : The Role of Chemokines–Part B, 2021 - Springer
The tumor microenvironment represents a dynamic and complex cellular network involving
intricate communications between the tumor and highly heterogeneous groups of cells …

A therapeutically actionable protumoral axis of cytokines involving IL-8, TNFα, and IL-1β

I Olivera, R Sanz-Pamplona, E Bolaños, I Rodriguez… - Cancer discovery, 2022 - AACR
Abstract Interleukin-8 (CXCL8) produced in the tumor microenvironment correlates with poor
response to checkpoint inhibitors and is known to chemoattract and activate …

The interleukin-8 pathway in cancer

DJJ Waugh, C Wilson - Clinical cancer research, 2008 - AACR
Abstract Interleukin-8 (IL-8) is a proinflammatory CXC chemokine associated with the
promotion of neutrophil chemotaxis and degranulation. This chemokine activates multiple …

Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression

K Fousek, LA Horn, C Palena - Pharmacology & therapeutics, 2021 - Elsevier
Tumor progression relies on the ability of cancer cells to effectively invade surrounding
tissues and propagate. Among the many mechanisms that contribute to tumor progression is …

Intratumorally establishing type 2 innate lymphoid cells blocks tumor growth

J Kim, W Kim, UJ Moon, HJ Kim, HJ Choi… - The Journal of …, 2016 - journals.aai.org
A long-standing question in the field of tumor immunotherapy is how Th2 cytokines block
tumor growth. Their antitumor effects are particularly prominent when they are secreted …

[HTML][HTML] Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies

S Muhammad, T Fan, Y Hai, Y Gao, J He - Molecular Cancer, 2023 - Springer
Abstract Interleukin-2 (IL-2) and its receptor (IL-2R) are essential in orchestrating immune
responses. Their function and expression in the tumor microenvironment make them …

CXCL13/CXCR5 signaling axis in cancer

M Hussain, D Adah, M Tariq, Y Lu, J Zhang, J Liu - Life sciences, 2019 - Elsevier
The tumor microenvironment comprises stromal and tumor cells which interact with each
other through complex cross-talks that are mediated by a variety of growth factors, cytokines …

Interleukin-8 in cancer pathogenesis, treatment and follow-up

C Alfaro, MF Sanmamed, ME Rodríguez-Ruiz… - Cancer treatment …, 2017 - Elsevier
Abstract Interleukin-8 (CXCL8) was originally described as a chemokine whose main
function is the attraction of a polymorphonuclear inflammatory leukocyte infiltrate acting on …